Drugs / CLENPIQ
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | CLENPIQ | — | 2017-11-28 | fda.gov ↗ |
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04113382 | Jun 2022 → Jun 2027 expected | — | Ferring Pharmaceuticals | Recruiting | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03198221 Comparator | Jul 2018 → Mar 2019 | — | The Cleveland Clinic | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Clenpiq | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03198221 ↗ |
| Route | Oral | “begin drinking the bowel preparation Clenpiq” NCT03198221 ↗ |